RCCLMS harbors recurrent mutations of TSC1/TSC2, MTOR, and/or ELOC(TCEB1) genes, consistent with hyperactive MTOR complex; while ccRCC demonstrates primary alterations in VHL gene (7). Here, ELOC is linked to nonpapillary renal cell carcinoma.